Metal complexes of alkyl-aryl dithiocarbamates: Structural studies, anticancer potentials and applications as precursors for semiconductor nanocrystals

Cytotoxicity of bismuth(III) dithiocarbamate derivatives by promoting a mitochondrial-dependent apoptotic pathway and suppressing MCF-7 breast adenocarcinoma cell invasion

We previously reported that the bismuth(III) dithiocarbamate derivative, bismuth diethyldithiocarbamate (1) exhibited greater cytotoxicity while inducing apoptosis via the intrinsic pathway in MCF-7 cells. We further evaluated the other bismuth(III) dithiocarbamate derivatives, Bi[S2CNR]3, with R = (CH2CH2OH)(iPr), (CH2)4, and (CH2CH2OH)(CH3), denoted as 2, 3, and 4, respectively, in the same MCF-7 cell line. 2-4 were found to exhibit IC50 values of 10.33 ± 0.06 µM, 1.07 ± 0.01 µM and 25.37 ± 0.12 µM, respectively, compared to that of cisplatin at 30.53 ± 0.23 µM. Apoptotic promotion via the mitochondrial-dependent pathway was due to the elevation of intracellular reactive oxygen species (ROS), promotion of caspases, release of cytochrome c, fragmentation of DNA, and results of staining assay observed in all compound-treated cells. 2-4 are also capable of suppressing MCF-7 cell invasion and modulate Lys-48 also Lys-63 linked polyubiquitination, leading to proteasomal degradation. Analysis of gene expression via qRT-PCR revealed their modulation, which supported all activities conducted upon treatment with 2-4. Altogether, bismuth dithiocarbamate derivatives, with bismuth(III) as the metal center bound to ligands, isopropyl ethanol, pyrrolidine, and methyl ethanol dithiocarbamate, are potential anti-breast cancer agents that induce apoptosis and suppress metastasis. Further studies using other breast cancer cell lines and in vivo studies are recommended to clarify the anticancer effects of these compounds.

Synthesis and Crystal Structures of Bis(diallydithiocarbamato)zinc(II) and Silver(I) Complexes: Precursors for Zinc Sulfide and Silver Sulfide Nanophotocatalysts

We report the preparation and crystal structures of bis(diallydithiocarbamato)zinc(II) and silver(I) complexes. The compounds were used as single-source precursors to prepare zinc sulfide and silver sulfide nanophotocatalysts. The molecular structure of bis(diallydithiocarbamato)zinc(II) consists of a dimeric complex in which each zinc(II) ion asymmetrically coordinates with two diallydithiocarbamato anions in a bidentate chelating mode, and the centrosymmetrically related molecule is bridged through the S-atom that is chelated to the adjacent zinc(II) ion to form a distorted trigonal bipyramidal geometry around the zinc(II) ions. The molecular structure of bis(diallydithiocarbamato)silver(I) formed a cluster complex consisting of a trimetric Ag₃S₃ molecule in which the diallydithiocarbamato ligand is coordinated to all the Ag(I) ions. The complexes were thermolyzed in dodecylamine, hexadecylamine, and octadecylamine (ODA) to prepare zinc sulfide and silver sulfide nanoparticles. The powder X-ray diffraction patterns of the zinc sulfide nanoparticles correspond to the hexagonal wurtzite while silver sulfide is in the acanthite crystalline phase. The high-resolution transmission electron microscopy images show that quantum dot zinc sulfide nanoparticles are obtained with particle sizes ranging between 1.98 and 5.49 nm, whereas slightly bigger silver sulfide nanoparticles are obtained with particle sizes of 2.70-13.69 nm. The surface morphologies of the ZnS and AgS nanoparticles capped with the same capping agent are very similar. Optical studies revealed that the absorption band edges of the as-prepared zinc sulfide and silver sulfide nanoparticles were blue-shifted with respect to their bulk materials with some surface defects. The zinc sulfide and silver sulfide nanoparticles were used as nanophotocatalysts for the degradation of bromothymol blue (BTB) and bromophenol blue (BPB). ODA-capped zinc sulfide is the most efficient photocatalyst and degraded 87% of BTB and 91% of BPB.

Addressing the gaps in homeostatic mechanisms of copper and copper dithiocarbamate complexes in cancer therapy: a shift from classical platinum-drug mechanisms

The platinum drug, cisplatin, is considered as among the most successful medications in cancer treatment. However, due to its inherent toxicity and resistance limitations, research into other metal-based non-platinum anticancer medications with diverse mechanisms of action remains an active field. In this regard, copper complexes feature among non-platinum compounds which have shown promising potential as effective anticancer drugs. Moreover, the interesting discovery that cancer cells can alter their copper homeostatic processes to develop resistance to platinum-based treatments leads to suggestions that some copper compounds can indeed re-sensitize cancer cells to these drugs. In this work, we review copper and copper complexes bearing dithiocarbamate ligands which have shown promising results as anticancer agents. Dithiocarbamate ligands act as effective ionophores to convey the complexes of interest into cells thereby influencing the metal homeostatic balance and inducing apoptosis through various mechanisms. We focus on copper homeostasis in mammalian cells and on our current understanding of copper dysregulation in cancer and recent therapeutic breakthroughs using copper coordination complexes as anticancer drugs. We also discuss the molecular foundation of the mechanisms underlying their anticancer action. The opportunities that exist in research for these compounds and their potential as anticancer agents, especially when coupled with ligands such as dithiocarbamates, are also reviewed.

Stereoelectronic Mapping of Dithiocarbamates and Xanthates

A library of 12 palladium(II) complexes of the type [PdBr(ⁱPr₂-bimy)(L∧X)] comprising 10 dithiocarbamato (R₂NCS₂^-) and two xanthato (ROCS₂^-) ligands have been prepared and fully characterized. With these complexes in hand, the electronic and steric properties of the bidentate, monoanionic ligands were evaluated using the HEP2 and %V_bur methodologies. Moreover, the construction of the first stereoelectronic map for dithiocarbamates enabled the in-principle identification of optimal ligand parameters for enhanced cytotoxic activities of their gold(III) complexes. This application of the stereoelectronic map showcases its viability as a useful tool to establish structure-activity relationships for rational ligand design.

The structural chemistry of zinc(ii) and nickel(ii) dithiocarbamate complexes

Dithiocarbamate complexes are of immense interest due to their diverse structural properties and extensive application in various areas. They possess two sulfur atoms that often act as the binding sites for metal coordination in a monodentate, bidentate, or anisodentate fashion. These different coordination modes enhance the possibility for complex formation and make them useful in different areas especially in biomedical fields. A synergy exists in the metal ions and dithiocarbamate moieties, which tends to exert better properties than the respective individual components of the complex. These improved properties have also been attributed to the presence of the C–S bonds. Zinc and nickel ions have been majorly found to bind to the dithiocarbamate in bidentate modes, and consequently different geometries have resulted from this interaction. The aim of this review is to present some studies on the synthesis, structural chemistry, and the relevance of zinc and nickel dithiocarbamates complexes especially in biological systems.

Two new monofunctional platinum(II) dithiocarbamate complexes: phenanthriplatin-type axial protection, equatorial-axial conformational isomerism, and anticancer and DNA binding studies

The syntheses of two platinum(ii) dithiocarbamate complexes (1 and 2) that show quinoplatin- and phenanthriplatin-type axial protection of the Pt-plane are described. The Pt-plane of complex 2 is axially more protected than that of complex 1. Furthermore, both complexes adopt two different stereochemical conformations in the solid state (based on single-crystal X-ray structures) owing to the structurally flexible piperazine backbone; i.e., C-e,e-Anti (1) and C-e,a-Syn (2), where "C" stands for the chair configuration, "e" and "a" stand for the equatorial and axial positions and "Anti" (opposite side) and "Syn" (same side) represent the relative orientations in space of the terminal substituents on the piperazine ring. In complex 2, the C-e,a-Syn conformation may provide additional steric hindrance to the Pt-plane. Despite the lower lipophilicity of 2 as compared to that of 1, the in vitro anticancer action against selected cancer cell lines is better for the former revealing the superior role of the axial protection over lipophilicity in modulating anticancer activity. The activity against the cancer promoting protein NF-κB signifies that the mode of cancer cell death may be the result of hindering the activity of NF-κB in the initiation of apoptosis. The apoptotic mode of cell death has been established earlier in a study using Annexin V-FITC. Finally, DNA binding studies revealed that the complex-DNA adduct formation is spontaneous and the mode of interaction is non-intercalative (electrostatic/covalent).

Synthesis, Crystal Structures and Anticancer Studies of Morpholinyldithiocarbamato Cu(II) and Zn(II) Complexes

Cu(II) and Zn(II) morpholinyldithiocarbamato complexes, formulated as [Cu(MphDTC)₂] and [Zn(μ-MphDTC)₂(MphDTC)₂], where MphDTC is morpholinyldithiocarbamate were synthesized and characterized by elemental analysis, spectroscopic techniques and single-crystal X-ray crystallography. The molecular structure of the Cu(II) complex revealed a mononuclear compound in which the Cu(II) ion was bonded to two morpholinyl dithiocarbamate ligands to form a four-coordinate distorted square planar geometry. The molecular structure of the Zn(II) complex was revealed to be dinuclear, and each metal ion was bonded to two morpholinyl dithiocarbamate bidentate anions, one acting as chelating ligand, the other as a bridge between the two Zn(II) ions. The anticancer activity of the morpholinyldithiocarbamate ligand, Cu(II) and Zn(II) complexes were evaluated against renal (TK10), melanoma (UACC62) and breast (MCF7) cancer cells by a Sulforhodamine B (SRB) assay. Morpholinyldithiocarbamate was more active than the standard drug parthenolide against renal and breast cancer cell lines, and [Zn(μ-MphDTC)₂(MphDTC)₂] was the most active complex against breast cancer. The copper(II) complex had a comparable activity with the standard against renal and breast cancer cell lines but showed an enhanced potency against melanoma when compared to parthenolide.

Room-Temperature Synthesis of ZnS Nanoparticles Using Zinc Xanthates as Molecular Precursors

Molecular precursors are suitable starting compounds for preparation of semiconductor nanoparticles (NPs), which allow for control of atomic ratio, composition, monodispersity, and particle size of nanoscaled metal sulfides/oxides. In the present study, we carried out a one-pot synthesis of ZnS NPs in aqueous triethanolamine medium at room temperature, from molecular precursor zinc xanthate as a source of both Zn²⁺ and S^2- ions. Furthermore, we compared the products obtained from zinc ethylxanthate (Zn(C₂H₅OCS₂)₂) and zinc amylxanthate (Zn(C₅H₁₁OCS₂)₂). The as-prepared ZnS NPs were found to crystallize in cubic phase, which usually forms at low temperatures, with the dimension dependent on the xanthate precursor used. The long carbon-chain xanthate Zn(C₅H₁₁OCS₂)₂ gave spherically shaped NPs with an average diameter of 19 nm, while the NPs that originated from zinc ethylxanthate had a mean size of ~26 nm. Both nanomaterials had surface sulfur vacancies that extended their absorption spectra toward the visible region and reduced the band gap. This allowed both materials to demonstrate photocatalytic performance under visible-light irradiation. Photodegradation of methylene blue over newly prepared ZnS NPs was tested under visible light, demonstrating efficiency of 50%-60% after 180 min.

Preparation and Photocatalytic Properties of CdS and ZnS Nanomaterials Derived from Metal Xanthate

In this paper, we report a new, simple method for the synthesis of CdS and ZnS nanoparticles (NPs) prepared in a basic aqueous medium using metal xanthate as the sulfur source. The structure, morphology, size distribution, optical band gap, and photocatalytic properties of the newly obtained nanomaterials were investigated by UV-Vis spectroscopy, X-ray diffraction, and transmission electron microscopy. The results show that both CdS and ZnS crystallized in cubic phase and formed NPs with average sizes of 7.0 and 4.2 nm for CdS and ZnS, respectively. A blue shift of UV-Vis absorbance band and higher energy band gap values were observed for both materials in comparison with their bulk counterparts, which is in accordance with the quantum confinement effect. The as-prepared nanomaterials were tested in visible-light driven photocatalytic decomposition of methylene blue (MB). After irradiation for 180 min, the degradation rate of MB with a concentration of 8 × 10-6 mol/L mixed with a photocatalyst (CdS or ZnS, both 10 mg in 100 mL solution of MB) was found to be 72% and 61%, respectively. The CdS NPs showed better photocatalytic activity than ZnS, which could be explained by their lower energy band gap and thus the ability to absorb light more efficiently when activated by visible-light irradiation.

Crystal structure of sodium morpholine-4-carbodithioate, (C5H12NNaO3S2)

C5H12NNaO3S2, monoclinic, P21/c (no. 14), a = 28.8222(3) Å, b = 5.6782(3) Å, c = 12.3810(9) Å, β = 102.074(2)°, V = 1987.43(17) Å3, Z = 8, R gt(F) = 0.0269, wR ref(F 2) = 0.0591, T = 100(2) K.

An innovative and efficient route to the synthesis of metal-based glycoconjugates: proof-of-concept and potential applications

With a view to developing more efficient strategies to the functionalization of metallodrugs with carbohydrates, we here report on an innovative and efficient synthetic route to generate gold(iii) glycoconjugates in high yields and purity. The method is based on the initial synthesis of the zinc(ii)-dithiocarbamato intermediate [Zn^II(SSC-Inp-GlcN)₂] (Inp = isonipecotic moiety; GlcN = amino-glucose) followed by the transfer of the glucoseisonipecoticdithiocarbamato ligand to the gold(iii) center via transmetallation reaction between the zinc(ii) intermediate and K[Au^IIIBr₄] in 1 : 2 stoichiometric ratio, yielding the corresponding glucose-functionalized gold(iii)-dithiocarbamato derivative [Au^IIIBr₂(SSC-Inp-GlcN)]. No protection/deprotection of the amino-glucose scaffold and no chromatographic purification were needed. The synthetic protocol was optimized for glucose precursors bearing the amino function at either the C² or the C⁶ position, and works in the case of both α and β anomers. The application of the synthetic strategy was also successfully extended to other metal ions of biomedical interest, such as gold(i) and platinum(ii), to obtain [Au^I(SSC-Inp-GlcN)(PPh₃)] and [Pt^II(SSC-Inp-GlcN)₂], respectively. All compounds were fully characterized by elemental analysis, mid- and far-IR, mono- and multidimensional NMR spectroscopy, and, where possible, X-ray crystallography. Results and potential applications are here discussed.

Synthesis, Optical, and Structural Studies of Iron Sulphide Nanoparticles and Iron Sulphide Hydroxyethyl Cellulose Nanocomposites from Bis-(Dithiocarbamato)Iron(II) Single-Source Precursors

In this study, Fe(II) complexes of phenyldithiocarbamate, dimethyldithiocarbamate and imidazolyldithiocarbamate were used as single-source precursors to prepare iron sulphide nanoparticles by thermolysis in oleic acid/octadecylamine (ODA) at 180 °C. The nanoparticles were dispersed into hydroxyethyl cellulose (HEC) to prepare iron sulphide/HEC nanocomposites. Ultraviolet-Visible (UV-Vis), Photoluminescence (PL), Fourier Transform Infrared (FTIR), powder X-ray diffraction (pXRD), high-resolution transmission electron microscopy (HRTEM), Field emission scanning electron microscopy (FESEM), and energy dispersive X-ray spectroscopy (EDS) were used to characterize the iron sulphide nanoparticles and corresponding HEC nanocomposites. The absorption spectra studies revealed that the nanoparticles were blue shifted due to quantum confinement and the optical band gaps of the nanoparticles are 4.85 eV for FeS1, 4.36 eV for FeS2, and 4.77 eV for FeS3. The emission maxima are red-shifted and broader for the nanoparticles prepared from phenyldithiocarbamate. Rod-like and spherically shaped iron sulphide particles were observed from the HRTEM images. The crystallite sizes from the HRTEM images are 23.90-38.89 nm for FeS1, 4.50-10.50 nm for FeS2, and 6.05-6.19 nm for FeS3 iron sulphide nanoparticles, respectively. pXRD diffraction patterns confirmed that FeS1 is in the pyrrhotite-4M crystalline phase, FeS2 is in the pyrrhotite phase, and FeS3 is in the troilite phase of iron sulphide. The phases of the iron sulphide nanoparticles indicate that the nature of the precursor complex affects the obtained crystalline phase. FTIR spectra studies confirmed the incorporation of the nanoparticles in the HEC matrix by the slight shift of the O-H and C-O bonds and the intense peaks on the nanoparticles. FESEM images of the iron sulphide nanoparticles showed flake-like or leaf-like morphologies with some hollow spheres. The EDS confirmed the formation of iron sulphide nanoparticles by showing the peaks of Fe and S.